Latest Insider Transactions at Caladrius Biosciences, Inc. (CLBS)
This section provides a real-time view of insider transactions for Caladrius Biosciences, Inc. (CLBS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CALADRIUS BIOSCIENCES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CALADRIUS BIOSCIENCES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
James Nisco SVP, Fin/Treas, Chief Actg Off |
SELL
Payment of exercise price or tax liability
|
Direct |
1,701
-11.61%
|
$3,402
$2.93 P/Share
|
|
Oct 01
2024
|
James Nisco SVP, Fin/Treas, Chief Actg Off |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+18.38%
|
$6,600
$2.93 P/Share
|
|
Oct 01
2024
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,363
-9.22%
|
$12,726
$2.93 P/Share
|
|
Oct 01
2024
|
Kristen K Buck EVP, R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+17.85%
|
$30,000
$2.93 P/Share
|
|
Oct 01
2024
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,964
-11.29%
|
$53,928
$2.93 P/Share
|
|
Oct 01
2024
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
58,000
+19.54%
|
$116,000
$2.93 P/Share
|
|
Jan 11
2024
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,026
-0.58%
|
$2,052
$2.99 P/Share
|
|
Jan 10
2024
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,470
-1.94%
|
$10,410
$3.0 P/Share
|
|
Jan 10
2024
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
512
-0.94%
|
$1,536
$3.0 P/Share
|
|
Jan 09
2024
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,046
-5.16%
|
$60,138
$3.08 P/Share
|
|
Jan 09
2024
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
94,000
+32.05%
|
-
|
|
Jan 09
2024
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,368
-4.58%
|
$16,104
$3.08 P/Share
|
|
Jan 09
2024
|
Kristen K Buck EVP, R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+31.06%
|
-
|
|
Jan 09
2024
|
Cynthia Schwalm Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,480
+28.36%
|
-
|
|
Jan 09
2024
|
Heidi Henson Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,480
+33.04%
|
-
|
|
Jan 09
2024
|
Steven M Klosk Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,480
+28.21%
|
-
|
|
Jan 09
2024
|
Mohammad Azab Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,480
+24.92%
|
-
|
|
Jan 09
2024
|
Gregory B Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,480
+28.28%
|
-
|
|
Sep 01
2023
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,908
-8.12%
|
$5,816
$2.18 P/Share
|
|
Jan 13
2023
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
397
-0.41%
|
$1,191
$3.65 P/Share
|
|
Jan 11
2023
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,030
-1.05%
|
$3,090
$3.2 P/Share
|
|
Jan 10
2023
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
512
-1.41%
|
$1,536
$3.19 P/Share
|
|
Jan 10
2023
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,470
-3.42%
|
$10,410
$3.19 P/Share
|
|
Jan 09
2023
|
Erkki Ruoslahti Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Jan 09
2023
|
David W. Slack President & CBO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,358
-13.99%
|
$10,074
$3.0 P/Share
|
|
Jan 09
2023
|
David W. Slack President & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+50.0%
|
-
|
|
Jan 09
2023
|
Mohammad Azab Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+33.78%
|
-
|
|
Jan 09
2023
|
Gregory B Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+40.05%
|
-
|
|
Jan 09
2023
|
Cynthia Schwalm Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+40.22%
|
-
|
|
Jan 09
2023
|
Heidi Henson Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Jan 09
2023
|
Steven M Klosk Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+39.93%
|
-
|
|
Jan 09
2023
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,147
-5.58%
|
$6,441
$3.0 P/Share
|
|
Jan 09
2023
|
Kristen K Buck EVP, R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+31.87%
|
-
|
|
Jan 09
2023
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,845
-7.18%
|
$23,535
$3.0 P/Share
|
|
Jan 09
2023
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+35.44%
|
-
|
|
Sep 15
2022
|
Mohammad Azab Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,200
+50.0%
|
$115,200
$6.25 P/Share
|
|
Sep 01
2022
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
69,742
-8.62%
|
$0
$0.5 P/Share
|
|
Sep 01
2022
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+15.64%
|
$0
$0.5 P/Share
|
|
Sep 01
2022
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
69,959
-9.7%
|
$0
$0.5 P/Share
|
|
Sep 01
2022
|
Kristen K Buck EVP, R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
58,000
+13.33%
|
$0
$0.5 P/Share
|
|
Jan 14
2022
|
Todd C Girolamo CLO, SVP of Corp Dev |
SELL
Payment of exercise price or tax liability
|
Direct |
2,158
-1.32%
|
$0
$0.82 P/Share
|
|
Jan 14
2022
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,611
-1.04%
|
$0
$0.82 P/Share
|
|
Jan 13
2022
|
Todd C Girolamo CLO, SVP of Corp Dev |
SELL
Payment of exercise price or tax liability
|
Direct |
2,563
-1.55%
|
$0
$0.81 P/Share
|
|
Jan 13
2022
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,471
-1.0%
|
$0
$0.81 P/Share
|
|
Jan 11
2022
|
Todd C Girolamo CLO, SVP of Corp Dev |
SELL
Payment of exercise price or tax liability
|
Direct |
4,722
-2.77%
|
$0
$0.87 P/Share
|
|
Jan 11
2022
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,740
-2.53%
|
$0
$0.87 P/Share
|
|
Jan 10
2022
|
Gregory B Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+30.51%
|
-
|
|
Jan 10
2022
|
Michael H. Davidson Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+23.78%
|
-
|
|
Jan 10
2022
|
Cynthia Schwalm Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+30.97%
|
-
|
|
Jan 10
2022
|
Steven M Klosk Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+30.18%
|
-
|